Here’s What Pfizer and Moderna Say is Next for Their Covid Vaccines

Three years and billions of Covid vaccinations into the pandemic, Pfizer and Moderna say their work is far from over. The two pharmaceutical companies are ushering in a new era for their shots that will elevate the role they play in protecting public health, but also simplify what people need to do to coexist with the virus. That involves developing new versions of the vaccines that aim to provide broader and longer-lasting immunity against the virus, and combination jabs that protect against Covid and other respiratory diseases in a single dose, among other efforts.

Pfizer and BioNTech are developing a vaccine that targets both Covid and the flu. The companies started a phase 1 trial for the shot in November and said they expect to launch it in 2024 or later. Many of Pfizer’s and Moderna’s plans for their vaccines may not reach the public for a few more years, and the success of those efforts isn’t guaranteed. Read more from CNBC here.